Skip to main content

Bacteria Disarm Phages by Disrupting Their Tail Assembly

Attachment of a bacterial protein to the tips of phage tails produces non-infectious, tailless phages.

Written byAndrea Lius, PhD
| 4 min read
3D rendered illustration of bacteriophages.
Register for free to listen to this article
Listen with Speechify
0:00
4:00

Microbiologists have studied bacterial defense mechanisms against phages for decades. But until less than a decade ago, there were only a few known bacterial immune systems: induced suicide mechanisms, restriction-modification, and CRISPR-Cas systems.1-3

In 2018, microbiologist Rotem Sorek and his colleagues at the Weizmann Institute revealed that bacterial antiphage defense mechanisms are much more diverse than originally thought.4 Since then, Sorek’s team and others have discovered a number of novel bacterial immune systems, including the Bil system (a primary component of the system is the Bil protein).5 Sorek next wanted to understand how the Bil system works.

Microscope image of tailless phages.
Negative staining transmission electron microscope image of tailless phages from lysates of Bil-expressing bacteria.
Jens Hör

In a recent study in Nature, Sorek and his colleagues showed that bacteria can use this system to covalently attach the bacterial protein Bil to the spike protein of an infecting phage’s tail, which is crucial for the tail assembly of its progenies and the infection of new host cells.6 The researchers noted that the presence of Bil in phage-infected bacteria resulted in the production of phage progenies that were either tailless or fully assembled but less infectious, protecting the rest of the bacterial population.

The Bil system is mechanistically similar to ubiquitin pathways because it involves the covalent attachment of ubiquitin-like proteins (Ubl) by ubiquitin-conjugating enzymes.7 Sorek’s interest in the Bil protein first piqued because of its structural similarity to interferon-stimulated gene 15 (ISG15), a human Ubl, which is how it got its name (bacterial ISG15-like, or Bil for short).8 In humans, ISG15 is part of an innate antiviral defense pathway that’s known to protect against HIV and influenza, although its mechanism is not well-understood.

Continue reading below...

Like this story? Sign up for FREE Microbiology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

“Many of these bacterial systems have been shown to be the evolutionary origin of different human immune systems,” said microbiologist Jens Hör, a former postdoctoral fellow in Sorek’s lab and coauthor of the study. “We thought that if we figure out how it works in bacteria, we might also advance the human field a bit.”

Image of Jens Hör
Jens Hör is a microbiologist at the Helmholtz Institute. Hör was a postdoctoral fellow in Rotem Sorek’s laboratory at the Weizmann Institute and coauthor of the study.
Jens Hör

Kevin Corbett, a structural biologist at the University of California, San Diego who was not involved in the study, said that Bil seems to truly resemble the eukaryotic ubiquitination machinery. Corbett and his group concurrently published a paper on the structural and molecular details of the Bil system in the same issue of Nature.9

“This is the first time that bacteria have been shown to perform protein conjugation using machinery like this, particularly a ubiquitin-like protein,” said Corbett.

Image of Kevin Corbett
Kevin Corbett, structural biologist at the University of California, San Diego. Corbett’s group concurrently published a paper that focused on the structural and molecular details of Bil in Nature.
Kevin Corbett

To understand how Bil works, Sorek’s team compared phage progeny from infected bacteria with and without the system. They performed density gradient centrifugation to separate phages from bacterial lysates and found that the bacteria that expressed Bil produced a higher density band in the gradient. When the scientists isolated the higher density band and viewed it under a transmission electron microscope, they were surprised by the sight of tailless phages. The team believes that the higher buoyant density could be explained by the higher DNA-to-protein ratio in tailless phages.

While not all the phage progenies end up tailless, Sorek and his team showed that even the fully assembled progenies showed a reduced capability of infecting other cells. By performing immunoprecipitation mass spectrometry, the authors showed that Bil is specifically conjugated to the spike protein at the tip of the phage’s tail. Hör said that Bil’s conjugation to the spike protein likely inhibits the interaction between the phage and its entry receptor on new host cells, which could explain why some of the tailed progenies are unable to infect.

Hör mentioned that some phages have enzymatic domains in their tails that could reverse Ubl conjugation reactions like the one performed by Bil. “One important question that we didn’t answer in our study is how phages can overcome bacterial defense by the Bil system,” he said.

  1. Lopatina A, et al. Abortive infection: Bacterial suicide as an antiviral immune strategy. Annu Rev Virol. 2020;7(1):371-384.
  2. Heitman J. On the origins, structures and functions of restriction-modification enzymes. Genet Eng (N Y). 1993;15:57-108.
  3. Hille F, Charpentier E. CRISPR-Cas: Biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci. 2016;371(1707):20150496.
  4. Doron S, et al. Systematic discovery of antiphage defense systems in the microbial pangenome. Science. 2018;359(6379):eaar4120.
  5. Millman A, et al. An expanded arsenal of immune systems that protect bacteria from phages. Cell Host Microbe. 2022;30(11):1556-1569.e5.
  6. Hör J, et al. Bacteria conjugate ubiquitin-like proteins to interfere with phage assembly. Nature. 2024;631(8022):850-856.
  7. Cappadocia L, Lima CD. Ubiquitin-like protein conjugation: Structures, chemistry, and mechanism. Chem Rev. 2018;118(3):889-918.
  8. Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018;16(7):423-439.
  9. Chambers LR, et al. A eukaryotic-like ubiquitination system in bacterial antiviral defence. Nature. 2024;631(8022):843-849.
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Image of Andrea Lius.

    Andrea Lius is an intern at The Scientist. She earned her PhD in pharmacology from the University of Washington. Besides science, she also enjoys writing short-form creative nonfiction.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo